1. Home
  2. RNA vs PAY Comparison

RNA vs PAY Comparison

Compare RNA & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • PAY
  • Stock Information
  • Founded
  • RNA 2012
  • PAY 2004
  • Country
  • RNA United States
  • PAY United States
  • Employees
  • RNA N/A
  • PAY N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • PAY Computer Software: Prepackaged Software
  • Sector
  • RNA Health Care
  • PAY Technology
  • Exchange
  • RNA Nasdaq
  • PAY Nasdaq
  • Market Cap
  • RNA 4.4B
  • PAY 4.8B
  • IPO Year
  • RNA 2020
  • PAY 2021
  • Fundamental
  • Price
  • RNA $29.31
  • PAY $32.05
  • Analyst Decision
  • RNA Strong Buy
  • PAY Hold
  • Analyst Count
  • RNA 14
  • PAY 5
  • Target Price
  • RNA $68.00
  • PAY $36.40
  • AVG Volume (30 Days)
  • RNA 1.4M
  • PAY 656.6K
  • Earning Date
  • RNA 08-08-2025
  • PAY 08-07-2025
  • Dividend Yield
  • RNA N/A
  • PAY N/A
  • EPS Growth
  • RNA N/A
  • PAY 74.18
  • EPS
  • RNA N/A
  • PAY 0.40
  • Revenue
  • RNA $8,927,000.00
  • PAY $962,105,000.00
  • Revenue This Year
  • RNA N/A
  • PAY $27.22
  • Revenue Next Year
  • RNA $155.06
  • PAY $20.11
  • P/E Ratio
  • RNA N/A
  • PAY $81.81
  • Revenue Growth
  • RNA N/A
  • PAY 47.78
  • 52 Week Low
  • RNA $21.51
  • PAY $16.94
  • 52 Week High
  • RNA $56.00
  • PAY $40.43
  • Technical
  • Relative Strength Index (RSI)
  • RNA 42.04
  • PAY 34.38
  • Support Level
  • RNA $31.59
  • PAY $32.33
  • Resistance Level
  • RNA $38.00
  • PAY $34.00
  • Average True Range (ATR)
  • RNA 2.01
  • PAY 1.46
  • MACD
  • RNA -0.59
  • PAY -0.73
  • Stochastic Oscillator
  • RNA 9.67
  • PAY 2.45

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

Share on Social Networks: